IPRIPR2026-00270Institution Denied
Sarepta Therapeutics, Inc. et al.v.Genzyme Corporation et al.
IPR challenge of US 12298313.
Type
IPR
Filed
Feb 26, 2026
Instituted
Jul 21, 2026
Decided
Jul 21, 2026
Patent
Application
19013863
Inventor
Xiaoying JIN et al
Granted
May 13, 2025
01
Timeline
3 milestones
2026-02-26Petition filed
2026-07-21Institution
2026-07-21Terminated
02
Parties & counsel
Petitioner
Sarepta Therapeutics, Inc. et al.
Counsel
Wilson, Robertet al
Patent Owner
Genzyme Corporation et al.
Counsel
Antons, Amandaet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →